Cargando…
Evaluation of the Use of Cancer Registry Data for Comparative Effectiveness Research
IMPORTANCE: Researchers often analyze cancer registry data to assess for differences in survival among cancer treatments. However, the retrospective, nonrandomized design of these analyses raises questions about study validity. OBJECTIVE: To examine the extent to which comparative effectiveness anal...
Autores principales: | Kumar, Abhishek, Guss, Zachary D., Courtney, Patrick T., Nalawade, Vinit, Sheridan, Paige, Sarkar, Reith R., Banegas, Matthew P., Rose, Brent S., Xu, Ronghui, Murphy, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009816/ https://www.ncbi.nlm.nih.gov/pubmed/32729921 http://dx.doi.org/10.1001/jamanetworkopen.2020.11985 |
Ejemplares similares
-
Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults
por: Kumar, Abhishek, et al.
Publicado: (2019) -
Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance
por: Nelson, Tyler J., et al.
Publicado: (2021) -
Association of Physician Referrals with Timely Cancer Care Using Tumor Registry and Claims Data
por: Schiaffino, Melody K., et al.
Publicado: (2022) -
Low-Value Prostate-Specific Antigen Screening in Older Males
por: Kalavacherla, Sandhya, et al.
Publicado: (2023) -
Association Between Primary Care Use Prior to Cancer Diagnosis and Subsequent Cancer Mortality in the Veterans Affairs Health System
por: Qiao, Edmund M., et al.
Publicado: (2022)